Physician profile
Jonathan C Waltman
NPI 1639181654
$1,880.23
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2020: $751 · 2021: $152 · 2022: $39.59 · 2024: $17.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $521.19 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $264.32 | 2019-2020 | |
| Abbott Laboratories | $161.67 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $107.68 | 2019-2020 | |
| Pfizer INC. | $105.23 | 2019-2020 | |
| Chiesi USA, INC. | $86.74 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $83.25 | 2019-2020 | |
| Amgen INC. | $72.70 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.72 | 2019 | |
| Lundbeck LLC | $57.33 | 2019-2020 | |
| Amarin Pharma, INC. | $56.53 | 2019-2020 | |
| Philips North America LLC | $53.72 | 2020 | |
| Esperion Therapeutics, INC. | $40.13 | 2020 | |
| Medtronic Vascular, INC. | $39.23 | 2019 | |
| Novo Nordisk INC | $24.88 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $20.87 | 2019 | |
| W. L. Gore & Associates, INC. | $17.21 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Cardinal Health 200 LLC | $13.66 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.24 | 2020 | |
| Gilead Sciences, INC. | $12.66 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.59 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.49 | 2019 | |
| Verge Medical, INC. | $12.29 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.88 | 2019 | |
| Cardiovascular Systems INC. | $7.16 | 2019 | |
| Bardy Diagnostics, INC. | $5.86 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Waltman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.